Invention Grant
- Patent Title: Selective phosphodiesterase 9A inhibitors as medicaments for improving cognitive processes
-
Application No.: US12769166Application Date: 2010-04-28
-
Publication No.: US08455502B2Publication Date: 2013-06-04
- Inventor: Frank-Gerhard Böss , Christina Erb , Martin Hendrix , Marja Van Kampen , Frank Wunder
- Applicant: Frank-Gerhard Böss , Christina Erb , Martin Hendrix , Marja Van Kampen , Frank Wunder
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Edouard G. Lebel; Edward S. Lazer
- Priority: DE10238722 20020823
- Main IPC: A61K31/59
- IPC: A61K31/59 ; A61K31/415
Abstract:
The invention relates to the use of selective phosphodiesterase 9A (PDE9A) inhibitors for producing medicaments for improving perception, concentration, cognitive processes, learning and/or memory.
Public/Granted literature
- US20100210839A1 SELECTIVE PHOSPHODIESTERASE 9A INHIBITORS AS MEDICAMENTS FOR IMPROVING COGNITIVE PROCESSES Public/Granted day:2010-08-19
Information query
